INTRODUCTION
The complete sequence of the human genome is expected to be available soon and a versatile method for large scale insertional mutagenesis will be a sine qua non for its functional analysis. Insertional mutagenesis and gene trapping with plasmid or retroviral vectors has been successfully applied in mammalian cultured cells (Gossler et al., 1989; Friedrich and Soriano, 1991; Wurst et al., 1995; Hicks et al., 1997; Bonaldo et al., 1998; Whitney et al., 1998; Zambrowicz et al., 1998; Wiles et al., 2000) . The efficiency of plasmid vectors is limited by low insertion rates, while retroviral vectors are relatively difficult to manipulate. Transposable elements present an attractive alternative. Transposable elements have been used previously as vectors for gene and enhancer trapping in various complex organisms, but not in mammals (Bier et al., 1989; Bellen et al., 1989; Wilson et al., 1989; Parinov and Sundaresan, 2000; Walbot, 2000) . Most elements are mobilized through a cut-andpaste process catalysed by an element-encoded transposase that excises the element from its original plasmid or chromosomal site and re-integrates it elsewhere in the genome. Minos (Franz and Savakis, 1991) belongs to the Tc1/mariner superfamily of transposable elements (Franz et al., 1994) , members of which are active in a wide range of species from protozoa to mammals (Gueiros-Filho and Beverley, 1997; Ivics et al., 1997; Schouten et al., 1998; Luo et al., 1998; Zhang et al., 1998; Yant et al., 2000) . Transposition of Minos in cultured cells or embryos of several insect species suggests that this element may serve as a universal gene transfer and mutagenesis vector in insects (Loukeris et al., 1995a,b; Catteruccia et al., 2000a,b; Shimizu et al., 2000) . Here we show that Minos is functional in human HeLa cells and that Minos-based vectors can be used for genome-wide mutagenesis and functional genomic analysis. We propose that Minos-based TRAMM (transposon mediated mutagenesis) may be a powerful tool for functional analysis of the human genome.
RESULTS AND DISCUSSION
To test for transposase-catalysed chromosomal integration of Minos in human cells, two circular Minos-based plasmids were co-transfected into HeLa cells: a helper plasmid (pEF1/ILMi) carrying the Minos transposase gene driven by the human EF1α (elongation factor 1α) promoter, and a donor plasmid (pMiLRneo) bearing a neomycin resistance gene driven by the SV40 promoter and flanked by Minos inverted repeats (Figure 1 ). Approximately 4% of the cells from each co-transfection, corresponding to 10 5 clones, were stably transformed to G418 resistance. A reduction ranging between 9-and 50-fold was observed in the absence of helper plasmid or in transfections with helper and pMiLneo, a 'wings clipped' donor lacking one of the two inverted repeats (Table I ). These differences were reproducible and independent of transfection efficiencies, as indicated by transient expression of a co-transfected CMV/GFP construct.
Genomic analysis of randomly selected clones derived from pMiLRneo and pEF1/ILMi co-transfection, indicated that single copies of the transposon had integrated at different genomic positions ( Figure 2A ). Restriction analysis failed to detect diagnostic fragments derived from integration of the entire donor plasmid ( Figure 2A , triple digest). Absence of plasmid vector sequences was confirmed by re-probing the blots with an appropriate probe (data not shown). Analysis of 30 clones showed between one and seven insertions per clone, with a mean of 2.1.
As with all Tc1/mariner elements, Minos insertions invariably disrupt a TA dinucleotide, which is duplicated upon insertion (Loukeris et al., 1995a) . We determined the DNA sequences scientific reports flanking the MiLRneo transposon of three different clones bearing single insertions. All insertions had occurred at a TA dinucleotide and the flanking sequences were different from the original Minos flanks. In clone 3, the pre-insertion site was cloned and sequenced; the TA duplication was the only alteration introduced ( Figure 2B ). The observed high integration frequencies suggested that genome-wide gene trapping is possible. A Minos-based genetrap construct (pMiLRgeo) was used, utilizing the first splice acceptor and part of exon 2 of the mouse Engrailed-2 gene fused in-frame to an AUG-less lacZ-neo fusion (geo, Figure 3A ). Upon insertion of geo vectors into introns of active genes in the appropriate orientation, in-frame splicing of the geo fusion to the upstream exon confers resistance to G418 and occasionally gives detectable galactosidase activity. Co-transfection of HeLa cells with pMiLRgeo plus pEF1/ILMi resulted in 10-to 100-fold lower frequency of G418-resistant clones compared with pMiLRneo. Transposase-induced insertions were 10-fold more frequent than in the absence of transposase. Southern blot analysis of five randomly chosen clones indicates that insertions occured in different genomic positions, varying in number from 1 to 10 per clone ( Figure 3B ). From 16 individual G418-resistant clones, eight were positive for β-galactosidase activity (data not shown). As in all random mutagenesis schemes, occurrence of multiple hits can complicate downstream analysis. This problem is of lesser concern in gene trap experiments, since gene traps are identified at the level of cDNA rather than at the genomic level.
A fusion transcript from clone T4 was recovered by 5′ RACE and the sequence of the splice junction was determined. Integration had occurred into the fourth intron of the monocarboxylate transporter 3 (MCT3) gene. Analysis of the insertion sequence showed that the transposon had inserted at a TA ∼1.7 kb upstream from exon 5, generating the characteristic target TA duplication ( Figure 3C) .
The restriction patterns shown in Figures 2 and 3 were unchanged after >50 passages, indicating that Minos insertions in HeLa cells are stable (data not shown).
Using standard protocols, transfection of 10 6 cells can yield ∼4 × 10 4 clones carrying Minos insertions. Since the average number of insertions per clone is ∼2 (Figure 2A ), this corresponds to a total number of 8 × 10 4 individual insertions per 10 6 transfected cells. Therefore, a library containing 3 × 10 6 insertions can be generated from 4 × 10 7 cells. Such a library should contain, on average, one insertion per kb. To further challenge Minos as a tool for genome-wide gene trapping, 4 × 10 7 HeLa cells distributed in twenty 100 mm tissue culture dishes were co-transfected with gene trap vector pMiLRgeo and helper pEF1/ ILMi. G418 selection yielded ∼10 5 G418-resistant colonies. Given that only a fraction of genes should be active in HeLa cells, Minos insertions should have occurred in the majority of active genes. To test this, five sets of four plates each were pooled to create sub-libraries of ∼2 × 10 4 clones each. Poly(A) + RNA was isolated from each pool, and was used to detect genetrap fusions of 12 genes whose intron-exon structure is known, and which have been reported or are expected to be active in HeLa cells (Ryo et al, 1998 ; see legend to Figure 4) . Fusion RT-PCR products were detectable for six of these genes without the need to optimize PCR conditions or use alternate primers. Four of the genes were hit in more than one pool and two were hit in more than one intron (Figure 4 and Table II ). It is notable that only two of the nine exon traps detected were in-frame. This suggests that the remaining fusions represent 'by-standers', i.e. that the respective cells may carry at least one other gene trap that confers G418 resistance. Considering the limitations of RT-PCR, that HeLa cells are largely polyploid, and taking into account that our sample (12 genes) is rather small, our experiments indicate that at least 50% of the genes that are active in HeLa cells have been tagged. Further experiments are required to determine whether the element inserts preferentially into transcriptionally active regions of the genome.
We show for the first time that a transposable element can potentially tag all genes of the human genome. Furthermore, we demonstrate that Minos-based TRAMM can be used for high efficiency gene trapping in a human cell line. Biological phenomena such as differentiation, response to external stimuli, and disease, frequently involve alterations of transcriptional levels of specific genes. This work opens the way to use Minosbased TRAMM for efficient genome-wide functional identification of transcriptionally modulated genes in cell lines. Minosbased TRAMM could also be useful for high-throughput screening of ES cells for potential knockouts.
METHODS

Plasmids.
Helper plasmid pEF1/ILMi was constructed by inserting the spliced transposase coding region into the ClaI-XbaI sites of plasmid pEF-BOS (Goldman et al., 1996) . Donor plasmid pMiLRneo was constructed by Each panel shows agarose gel electrophoresis separated, ethidium bromide stained RT-PCR products that were recovered from five independent pools (A-E) of G418-resistant clones. The control lane corresponds to a reaction without template. The panels correspond to genes (accession numbers in brackets): elongation factor 1γ (EF1γ) (Z11531); ribosomal protein 18 (rs18) (X69150); DNA replication licensing factor homolog (hRlf) (D39073); G 1 to S phase transition protein 1 homolog (GSPT1) (X17644); heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) (D28877); ATP synthase c-subunit (ATP-c) (X69908). Genes that were not detected are: thymidine kinase (M15205), ATP synthase γ-subunit (D16561), F-actin capping protein (U03271), a putative protein kinase C inhibitor (U51004), hypoxantine phosphoribosyltransferase 1 (NM_000194) and cytochrome c core I protein (L16842). Sequence a EF1γ 4 1 3.4 …gct gac atc aca gtt gtc tgc acc ctg ttg tgg ctc tat aag cag GT CCC AGG… EF1γ 5 2 0.4 …tc ttg ggg gaa gtg aaa ctg tgt gag aag atg gcc cag ttt gat gGT CCC AGG… EF1γ 6 2 5.7 …gct gag ccc aag gcc aag gac ccc ttc gct cac ctg ccc aag ag GT CCC AGG… rs18 1 2 3.0 …att gat ggg cgg cgg aaa ata gcc ttt gcc atc act gcc att aag GT CCC AGG… hRlf 9 1 2.3 …gcc cgc tgc agt gtt ttg gca gct gcc aac cct gtc tac ggc agg GT CCC AGG… GSPT1 9 1 5.4 …gga tct att tgt aaa ggc cag cag ctt gtg atg atg cca aac aag GT CCC AGG… GSPT1 13 1 2.5 …tt aaa gac ttc cct cag atg ggt cgt ttc acc tta aga gatgag gGT CCC AGG… hnRNP 1 3 2.7 …ga aat cgg gct gaa gcg act gag tcc gcg atg gag GT CCC AGG… ATP-c 4 1 3.7 …tgg gat tgg aac tgt gtt tgg gag cct cat cat tgg tta tgc cag GT CCC AGG… scientific reports replacing the tetracycline resistance gene in pMiLRTetR by a SV40-neo cassette (pRcCMV, Invitrogen). 'Wings-clipped' pMiLneo is pMiLRneo lacking a SacII-SacI fragment containing the Minos right-hand inverted repeat. The gene-trap plasmid vector pMiLRgeo was constructed by replacing the SV40-neo cassette from pMiLRneo with an EcoRI-HindIII geo cassette from plasmid pGT1.8geo (Skarnes et al., 1995) . Cell culture and transfection. HeLa cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal calf serum and 50 μg/ml gentamycin at 37°C, 5% CO 2 . Exponentially growing HeLa cells (6 × 10 5 ) were transfected in 3 ml DMEM with 8 μg pMiLRneo or pMiLneo and 2 μg pEF-BOS or pEF1/ILMi, using calcium phosphate precipitation. One microgram of plasmid pQBI25 (Quantum) containing a GFP gene under the control of the cytomegalovirus promoter was included in all mixes for reference. Two days post-transfection, the cells were transferred to medium containing 600 μg/ml G418 (Gibco). Amplification and cloning of the insertion sites. Genomic DNA from three clones with single insertions was digested with EcoRV and probed with a neo probe. The gel regions containing the Minos flanks were cut out and DNA was isolated and digested with either Sau3AI or AluI. The Sau3AI fragments were ligated to vectorettes (Vectorette II kit, Genosys) and PCR was performed with vectorette-specific primers and the Minos primers: IMio1 (5′-AAGAGAATAAAATTCTCTTTGAGACG-3′) for the first PCR and IMio2 (5′-GATAATATAGTGTGTTAAACATTGCGC-3′) for the 'nested' PCR. The AluI fragments were circularized after dilution and inverse PCR was performed with Minos primers, IMio1 and IMii1 (5′-CAAAAATATGAGTAATTTATTCAAACGG-3′), followed by a second round of 'nested' PCR with primers IMio2 and IMii2 (5′-GCTTAAGAGATAAGAAAAAAGTGACC-3′). At least one flank of each insertion was recovered. The 'right-hand' flank from one of the clones (clone 3) was recovered by screening a human genomic library with the left flank as probe and using the sequence adjacent to the known flank for primer design. The preinsertion site sequence of clone 3 was recovered from non-transfected HeLa DNA by PCR. Amplification and cloning of fusion cDNAs. A modification of the 5′ RACE protocol (cRACE) was used to identify fusion cDNAs (Maruyama et al., 1995) . Total RNA was reverse transcribed with AMV reverse transcriptase (Gibco) using the geo specific primer ZRT (5′-GACCGTAATGGGATAGGTTAC-3′). The geo specific primers used for inverse PCR were: ZF1 (5′-CAGTTGCGCAGC-CTGAATGGG-3′) and ZR1 (5′-CTTCGCTATTACGCCAGCTGG-3′) for the first PCR; and ZF2 (5′-GCTGGCTGGAGTGCGATC-TTC-3′) and ZR2 (5′-CAGGGTTTTCCCAGTCACGAC-3′) for the 'nested' PCR. The right-hand flank of the insertion was isolated by PCR using Minos primer IMio1 and MCT3 exon 5 primer GGCTTCTTCCTAATGCAG. The left flank and the pre-insertion site in the MCT3 intron were recovered as described above for the MiLRneo insertion. Identification of trapped genes by RT-PCR. Reverse transcription was performed with the Superscript II system (Gibco) using 0.5 μg poly(A) + RNA from each pool as template and primer ZR1. Gene-trap insertions were identified using nested PCR with two geo-specific primers (ZR2 for the first and TGCTCTGTCAG-GTACCTGTTGG for the second PCR) and two gene-specific primers (sequences of gene-specific primers available upon request). Amplification products were analysed by agarose gel electrophoresis. Individual bands were eluted from the gel and cloned in a TA vector (Promega T-easy).
